NETSCOUT Advances AI-Driven Network Operations for TM Forum’s NeuroNOC: The Self-Healing Network Brain Catalyst Project
High-fidelity data enabled AI agent’s swift resolution of a simulated issue while reducing data tokenization with AWS Bedrock by an estimated 80%
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT), a leading provider of observability, AIOps, cybersecurity, and DDoS attack protection solutions, today announced its recent participation in TM Forum’s NeuroNOC Catalyst, an innovation project at DTW Ignite 2025, which set records for having the most Communication Service Providers and countries represented at a DTW Ignite event. TM Forum is a global alliance of telco and tech companies, leading the industry in defining the building blocks for new operating models, impactful new partnerships, and advanced software platforms. The NeuroNOC Catalyst project explored how AI agents, closed-loop automation, and high-quality network data can enable self-healing operations across telecom environments.
Developed in collaboration with global leaders, including Amazon Web Services, Accenture, Symphonica, and Sand Technologies—and championed by carriers such as BT Group, Telecom Argentina, Omantel, Turknet, Axian Telecom, and Safaricom—the NeuroNOC initiative demonstrated how AI and automation can dramatically accelerate fault detection and resolution in live network environments.
NETSCOUT deployed its Omnis AI Insights Solution, consisting of Omnis AI Sensor and Omnis AI Streamer, to deliver 5G Standalone Radio Access Network (SA RAN) and Packet Core high-fidelity telemetry essential for effective AI-driven operations. Omnis AI Sensor utilizes NETSCOUT’s signature deep packet inspection (DPI)-based, end-to-end network visibility, and Omnis AI Streamer provides powerful analytics and filtering at source via an open API driven dataset. In simulated service-impact scenarios, the solution enabled network operations center (NOC) engineers to identify subscriber registration issues, pinpoint the root cause via a curated large language model (LLM), and execute remediation steps with minimal manual effort.
The key takeaway was strong empirical validation of the need for high-quality curated data to drive effective AI solutions. Without data quality, AI models are hollow shells incapable of delivering valuable results, and data curation can unleash great power to ensure better outcomes. Moreover, the project showed promising results, including an expected 80% reduction in manual troubleshooting and up to 50% lower operational costs for communications service providers. It further reduced data usage and tokenization by AI models like AWS Bedrock by up to 80%, pointing to additional potential savings.
“Accurate, real-time curated data is the foundation of intelligent network operations. Without high-quality packet collection across the network, it’s nearly impossible to correlate issues across multiple data streams, determine root causes, and verify and test automated fixes,” said Richard Fulwiler, a Catalyst participant and Senior Director, Product Management at NETSCOUT. “While fully autonomous networks are still in their early stages, this project shows the powerful potential of AI agents – armed with the right data in real-time – to support faster and more accurate resolution of network issues.”
For more information on the NeuroNOC Catalyst project, visit TM Forum’s NeuroNOC Catalyst page. Please visit our website to learn more about NETSCOUT’s AIOps solutions for service providers.
About NETSCOUT
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) protects the connected world from cyberattacks and performance and availability disruptions through its unique visibility platform and solutions powered by its pioneering deep packet inspection at scale technology. NETSCOUT serves the world’s largest enterprises, service providers, and public sector organizations. Learn more at www.netscout.com or follow @NETSCOUT on LinkedIn, X, or Facebook.
©2025 NETSCOUT SYSTEMS, INC. All rights reserved. Third-party trademarks mentioned are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250710782355/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom